The Yale Center for Analytical Sciences (YCAS) at the Yale School of Public Health has received $6.65 million in funding to support D-CARE, a six-year pragmatic randomized controlled trial involving 2,150 individuals with dementia and their caregivers. The trial will compare the effectiveness and cost-effectiveness of two evidence-based models of dementia care over 18 months. The $6.65 million in funding will be directed toward YCAS’s Data Coordinating Center, which will provide advanced data management and analysis for the clinical trial.
The funding was provided by the National Institute on Aging ($3.35 million) and the Patient-Centered Outcomes Research Institute ($3.3 million). YCAS director, Dr. Peter Peduzzi, professor of biostatistics at the Yale School of Public Health, serves as principal investigator for the YCAS Data Coordinating Center’s portion of the project. The primary principal investigator for the D-CARE project is Dr. David Reuben of the University of California, Los Angeles. The two primary outcomes being studied in the clinical trial are participants’ behavioral symptoms and resulting caregiver distress.Tags: Friday Letter Submission, Publish on August 16